Gutiérrez-García A, Sánchez-Ocampo EM

Language: Spanish
References: 12
Page: 218-222
PDF size: 187.44 Kb.

Text Extraction

No abstract.

REFERENCES

1. Young WF Jr. Chapter 15 – Endocrine hypertension. In: Kronenberg HM, editors. Williams textbook of endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier; 2008.

2. Goldman: Cecil Medicine. Chapter 246 – Adrenal medulla, catecholamines, and pheochromocytoma. William F. Young Jr. 23rd ed. Saunders Elsevier; 2007.

3. Borontini M, Levin G. Fisiopatología endocrinológica: bioquímica y métodos diagnósticos. Fascículo V. Médula suprarrenal: bases fisiológicas, fisiopatológicas y su diagnóstico. Química Montpellier; 2006.

4. Leonevol M, Ragonnet B, Martin C. Simpaticomiméticos: farmacología e indicaciones terapéuticas en reanimación. EMC-Anestesia y Reanimación. 2015;41:1-16.

5. Bellomo R, Chapman M, Finfer S. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial: Australian and New Zealand Intensive Care Society Clinical Trials Group. Lancet. 2000;356:2139-2143.

6. Kellum J, Decker J. The use of dopamine in acute renal failure: a metaanalysis. Crit Care Med. 2001;29:1526-1531.

7. Kellum J, Pinsky M. Use of vasopressor agents in critically ill patients. Curr Opin Crit Care. 2002;8:236.

8. Bonow RO, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiology. 2008;52:1-142.

9. Jakob SM, Ensinger H, Takala J. Metabolic changes after cardiac surgery. Curr Opin Nutr Metab Care. 2001;4:14-155.

10. Moom M, et al. Treatment of aortic dissection. Surg Clin N Am. 2009;89:869-889.

11. Evangelista A, Tornos P, Sambola A, et al. Role of vasodilatorns in regurgitant valve disease. Curr Treat Options Cardiovasc Med. 2008;8:428-434.

12. Lobato E, Gravenstein N, Martin T. Milrinonenot epinephrine, improves left ventricular compliance after cardiopulmonary bypass. Jour Cardiothorac Vasc Anesth. 2000;14:347-377.